Published in Mol Cells on July 08, 2009
Modulation by Syk of Bcl-2, calcium and the calpain-calpastatin proteolytic system in human breast cancer cells. Biochim Biophys Acta (2013) 0.78
Transduction of receptor signals by beta-arrestins. Science (2005) 9.87
A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J Biol Chem (1997) 3.12
Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation. Structure (2001) 2.66
Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1. J Biol Chem (1997) 1.93
Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxy terminus. J Biol Chem (1997) 1.88
Activation-dependent conformational changes in {beta}-arrestin 2. J Biol Chem (2004) 1.76
How does arrestin respond to the phosphorylated state of rhodopsin? J Biol Chem (1999) 1.65
The active conformation of beta-arrestin1: direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of beta-arrestins1 and -2. J Biol Chem (2007) 1.41
Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem (2000) 1.38
PTP-PEST: a protein tyrosine phosphatase regulated by serine phosphorylation. EMBO J (1994) 1.25
Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2. Am J Physiol (1998) 1.11
Type 1 angiotensin receptor pharmacology: signaling beyond G proteins. Pharmacol Ther (2006) 1.02
Selective proteolysis of arrestin by calpain. Molecular characteristics and its effect on rhodopsin dephosphorylation. J Biol Chem (1995) 0.91
Serine phosphorylation of protein tyrosine phosphatase (PTP1B) in HeLa cells in response to analogues of cAMP or diacylglycerol plus okadaic acid. Mol Cell Biochem (1993) 0.89
Manifold active-state conformations in GPCRs: agonist-activated constitutively active mutant AT1 receptor preferentially couples to Gq compared to the wild-type AT1 receptor. FEBS Lett (2007) 0.88
The Protein-tyrosine-phosphatase SHP2 is phosphorylated on serine residues 576 and 591 by protein kinase C isoforms alpha, beta 1, beta 2, and eta. Biochemistry (2002) 0.88
Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes. Arch Biochem Biophys (1996) 0.84
Angiotensin II signalling events mediated by tyrosine phosphorylation. Cell Signal (1996) 0.80
Site-specific cleavage of G protein-coupled receptor-engaged beta-arrestin. Influence of the AT1 receptor conformation on scissile site selection. J Biol Chem (2008) 0.79
Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci U S A (2003) 3.99
Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development (2007) 2.70
TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol (2004) 2.68
Multiple signaling states of G-protein-coupled receptors. Pharmacol Rev (2005) 1.73
A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4. J Biol Chem (2004) 1.53
Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan. Hypertens Res (2012) 1.51
Interaction of G-protein βγ complex with chromatin modulates GPCR-dependent gene regulation. PLoS One (2013) 1.43
Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor. J Biol Chem (2006) 1.38
Cis- and trans-activation of hormone receptors: the LH receptor. Mol Endocrinol (2002) 1.18
Molecular analysis of the structure and function of the angiotensin II type 1 receptor. Hypertens Res (2003) 1.15
The contribution of Notch1 to nephron segmentation in the developing kidney is revealed in a sensitized Notch2 background and can be augmented by reducing Mint dosage. Dev Biol (2009) 1.14
Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state. Mol Endocrinol (2007) 1.12
Domain coupling in GPCRs: the engine for induced conformational changes. Trends Pharmacol Sci (2011) 1.12
Notch pathway activation can replace the requirement for Wnt4 and Wnt9b in mesenchymal-to-epithelial transition of nephron stem cells. Development (2011) 1.10
Ligand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor. J Biol Chem (2010) 1.10
Review: angiotensin II type 1 receptor blockers: class effects versus molecular effects. J Renin Angiotensin Aldosterone Syst (2010) 1.08
"Network leaning" as a mechanism of insurmountable antagonism of the angiotensin II type 1 receptor by non-peptide antagonists. J Biol Chem (2004) 1.08
Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J Biol Chem (2005) 1.07
Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents. Cancer Biol Ther (2005) 1.04
A small difference in the molecular structure of angiotensin II receptor blockers induces AT₁ receptor-dependent and -independent beneficial effects. Hypertens Res (2010) 1.03
Recent structural alteration of the peripheral lamina cribrosa near the location of disc hemorrhage in glaucoma. Invest Ophthalmol Vis Sci (2014) 1.03
Regulation of histone deacetylase 4 expression by the SP family of transcription factors. Mol Biol Cell (2005) 1.02
Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy. Cardiovasc Res (2010) 1.00
Trans-activation of mutant follicle-stimulating hormone receptors selectively generates only one of two hormone signals. Mol Endocrinol (2004) 0.98
Activation of extracellular signal-activated kinase by angiotensin II-induced Gq-independent epidermal growth factor receptor transactivation. Hypertens Res (2004) 0.98
TM2-TM7 interaction in coupling movement of transmembrane helices to activation of the angiotensin II type-1 receptor. J Biol Chem (2002) 0.97
Constitutive activation of angiotensin II type 1 receptor alters the orientation of transmembrane Helix-2. J Biol Chem (2002) 0.95
Antibiotic resistance and assessment of food-borne pathogenic bacteria in frozen foods. Arch Pharm Res (2010) 0.95
Purification and properties of an extracellular esterase from a cold-adapted Pseudomonas mandelii. Biotechnol Lett (2012) 0.91
Genome sequence of cold-adapted Pseudomonas mandelii strain JR-1. J Bacteriol (2012) 0.91
Relationship of intraocular pressure and frequency of spontaneous retinal venous pulsation in primary open-angle glaucoma. Ophthalmology (2012) 0.90
Long range effect of mutations on specific conformational changes in the extracellular loop 2 of angiotensin II type 1 receptor. J Biol Chem (2012) 0.89
G-protein-dependent cell surface dynamics of the human serotonin1A receptor tagged to yellow fluorescent protein. Biochemistry (2004) 0.89
Angiotensinergic stimulation of vascular endothelium in mice causes hypotension, bradycardia, and attenuated angiotensin response. Proc Natl Acad Sci U S A (2006) 0.89
Unconventional homologous internalization of the angiotensin II type-1 receptor induced by G-protein-independent signals. Hypertension (2005) 0.89
Manifold active-state conformations in GPCRs: agonist-activated constitutively active mutant AT1 receptor preferentially couples to Gq compared to the wild-type AT1 receptor. FEBS Lett (2007) 0.88
Glucocorticoids modulate NF-kappaB-dependent gene expression by up-regulating FKBP51 expression in Newcastle disease virus-infected chickens. Mol Cell Endocrinol (2007) 0.84
Guided resonances in asymmetrical GaN photonic crystal slabs observed in the visible spectrum. Opt Express (2005) 0.84
Modulation of the anti-cancer efficacy of microtubule-targeting agents by cellular growth conditions. Cancer Biol Ther (2010) 0.84
Comparison of the antimelanogenic effects of p-coumaric acid and its methyl ester and their skin permeabilities. J Dermatol Sci (2011) 0.83
Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors. Biochem Biophys Res Commun (2009) 0.83
High-power room-temperature continuous-wave mid-infrared interband cascade lasers. Opt Express (2012) 0.82
Small molecules with similar structures exhibit agonist, neutral antagonist or inverse agonist activity toward angiotensin II type 1 receptor. PLoS One (2012) 0.82
Mechanism of GPCR-directed autoantibodies in diseases. Adv Exp Med Biol (2012) 0.82
Trans-activation, cis-activation and signal selection of gonadotropin receptors. Mol Cell Endocrinol (2006) 0.82
Identification of synaptic pattern of kainate glutamate receptor subtypes on direction-selective retinal ganglion cells. Neurosci Res (2007) 0.80
Reassessment of the unique mode of binding between angiotensin II type 1 receptor and their blockers. PLoS One (2013) 0.80
Clinical and pharmacotherapeutic relevance of the double-chain domain of the angiotensin II type 1 receptor blocker olmesartan. Clin Exp Hypertens (2010) 0.80
Evaluation of the inhibition of mushroom tyrosinase and cellular tyrosinase activities of oxyresveratrol: comparison with mulberroside A. J Enzyme Inhib Med Chem (2011) 0.79
Site-specific cleavage of G protein-coupled receptor-engaged beta-arrestin. Influence of the AT1 receptor conformation on scissile site selection. J Biol Chem (2008) 0.79
Biotransformation of mulberroside A from Morus alba results in enhancement of tyrosinase inhibition. J Ind Microbiol Biotechnol (2010) 0.79
MicroRNAs--regulators of signaling networks in dilated cardiomyopathy. J Cardiovasc Transl Res (2010) 0.78
Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3. Biochim Biophys Acta (2012) 0.78
Angiotensin II receptor-induced cardiac remodeling in mice without angiotensin II. Hypertension (2012) 0.78
Complete genomic structure of human rpS3: identification of functional U15b snoRNA in the fifth intron. Gene (2002) 0.77
Leveraging crystal anisotropy for deterministic growth of InAs quantum dots with narrow optical linewidths. Nano Lett (2013) 0.77
One-pot aqueous phase growth of biocompatible 15-130 nm gold nanoparticles stabilized with bidentate PEG. J Colloid Interface Sci (2012) 0.77
Prospective markers for early diagnosis and prognosis of sporadic pancreatic ductal adenocarcinoma. Dig Dis Sci (2012) 0.77
Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease. J Neurol (2012) 0.77
Cardiac angiotensin II receptors as predictors of transplant coronary artery disease following heart transplantation. Eur Heart J (2004) 0.77
Genomic structure and transcriptional studies on the mouse ribosomal protein S3 gene: expression of U15 small nucleolar RNA. Gene (2005) 0.77
Ionotropic glutamate receptor GluR1 in the visual cortex of hamster: distribution and co-localization with calcium-binding proteins and GABA. Acta Histochem Cytochem (2006) 0.76
Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4. Eur J Biochem (2002) 0.76
Colorectal cancer in the cotton top tamarin (Saguinus oedipus): how do they evade liver metastasis? Dig Dis Sci (2010) 0.76
Abilities of candesartan and other AT(1) receptor blockers to impair angiotensin II-induced AT(1) receptor activation after wash-out. J Renin Angiotensin Aldosterone Syst (2011) 0.75
Correction: Interaction of G-Protein βγ Complex with Chromatin Modulates GPCR-Dependent Gene Regulation. PLoS One (2016) 0.75
AT1 receptor induced alterations in histone H2A reveal novel insights into GPCR control of chromatin remodeling. PLoS One (2010) 0.75
Pulsed and CW performance of 7-stage interband cascade lasers. Opt Express (2014) 0.75
Chirality-Selective Functionalization of Semiconducting Carbon Nanotubes with a Reactivity-Switchable Molecule. J Am Chem Soc (2017) 0.75
Wafer-scale nanowell array patterning based electrochemical impedimetric immunosensor. J Biotechnol (2013) 0.75
A fluorogenic method for measuring enteropeptidase activity: spectral shift in the emission of GD4K-conjugated 7-amino-4-methylcoumarin. BMB Rep (2011) 0.75
High-power continuous-wave interband cascade lasers with 10 active stages. Opt Express (2015) 0.75
Spectral narrowing and stabilization of interband cascade laser by volume Bragg grating. Appl Opt (2016) 0.75
Induction of insulin receptor substrate-2 expression by Fc fusion to exendin-4 overexpressed in E. coli: a potential long-acting glucagon-like peptide-1 mimetic. BMB Rep (2010) 0.75
Divergent Spatiotemporal Interaction of Angiotensin Receptor Blocking Drugs with Angiotensin Type1 Receptor. J Chem Inf Model (2017) 0.75
Compact photoacoustic module for methane detection incorporating interband cascade light emitting device. Opt Express (2017) 0.75
Five models of players' rule behavior for game balance. Cyberpsychol Behav Soc Netw (2012) 0.75
Continuous-wave interband cascade lasers operating above room temperature at λ = 4.7-5.6 μm. Opt Express (2012) 0.75
Performance characteristics of a continuous-wave compact widely tunable external cavity interband cascade lasers. Opt Express (2010) 0.75